{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/BEAM/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T18:59:11.199Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9370,"canonical_name":"Beam Therapeutics Inc.","cik":"0001745999","uei":null,"lei":null,"duns":null,"ticker":"BEAM"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":29},"count":29,"timeline":[{"ts":"2026-10-02","kind":"sec.filing","form_type":"4","title":"4 — Beam Therapeutics Inc. — 2026-10-02","url_slug":"/sec/cik-0001745999/4/0001193125-26-412236","accession_number":"0001193125-26-412236","importance":30},{"ts":"2026-09-25","kind":"sec.filing","form_type":"4","title":"4 — Beam Therapeutics Inc. — 2026-09-25","url_slug":"/sec/cik-0001745999/4/0001193125-26-402814","accession_number":"0001193125-26-402814","importance":30},{"ts":"2026-08-13","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Beam Therapeutics Inc. — 2026-08-13","url_slug":"/sec/cik-0001745999/schedule-13g-a/0000908834-26-000397","accession_number":"0000908834-26-000397","importance":30},{"ts":"2026-08-04","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Beam Therapeutics Inc. — 2026-08-04","url_slug":"/sec/cik-0001745999/10-q/0001193125-26-331541","accession_number":"0001193125-26-331541","importance":45},{"ts":"2026-08-04","kind":"sec.filing","form_type":"8-K","title":"8-K — Beam Therapeutics Inc. — 2026-08-04","url_slug":"/sec/cik-0001745999/8-k/0001193125-26-331522","accession_number":"0001193125-26-331522","importance":35},{"ts":"2026-07-29","kind":"sec.filing","form_type":"4","title":"4 — Beam Therapeutics Inc. — 2026-07-29","url_slug":"/sec/cik-0001745999/4/0001193125-26-323640","accession_number":"0001193125-26-323640","importance":30},{"ts":"2026-07-27","kind":"sec.insider.s","reporter":"Simon Amy","title":"Chief Medical Officer","shares":16667,"price_per_share":25.7417,"usd_value":429037,"security_title":"Common Stock","importance":35.4290369139},{"ts":"2026-07-27","kind":"sec.filing","form_type":"144","title":"144 — Beam Therapeutics Inc. — 2026-07-27","url_slug":"/sec/cik-0001745999/144/0001950047-26-007314","accession_number":"0001950047-26-007314","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — Beam Therapeutics Inc. — 2026-07-02","url_slug":"/sec/cik-0001745999/4/0001193125-26-294478","accession_number":"0001193125-26-294478","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"4","title":"4 — Beam Therapeutics Inc. — 2026-07-01","url_slug":"/sec/cik-0001745999/4/0001193125-26-292526","accession_number":"0001193125-26-292526","importance":30},{"ts":"2026-06-30","kind":"sec.form144","reporter":"JOHN M EVANS","title":"Officer, Director","shares":25000,"usd_value":857685,"security_title":"Common","approx_sale_date":"2026-06-30","accession_number":"0001950047-26-006639","importance":40.171537},{"ts":"2026-06-30","kind":"sec.insider.s","reporter":"Evans John M.","title":"CEO","shares":23100,"price_per_share":34.2633,"usd_value":791482,"security_title":"Common Stock","importance":35.79148223},{"ts":"2026-06-30","kind":"sec.insider.s","reporter":"Evans John M.","title":"CEO","shares":1900,"price_per_share":34.8437,"usd_value":66203,"security_title":"Common Stock","importance":35.06620303},{"ts":"2026-06-30","kind":"sec.insider.s","reporter":"Simon Amy","title":"Chief Medical Officer","shares":373,"price_per_share":34.73,"usd_value":12954,"security_title":"Common Stock","importance":35.01295429},{"ts":"2026-06-30","kind":"sec.filing","form_type":"144","title":"144 — Beam Therapeutics Inc. — 2026-06-30","url_slug":"/sec/cik-0001745999/144/0001950047-26-006639","accession_number":"0001950047-26-006639","importance":30},{"ts":"2026-06-30","kind":"sec.insider.m","reporter":"Evans John M.","title":"CEO","shares":25000,"price_per_share":1.03,"usd_value":25750,"security_title":"Common Stock","importance":15.02575},{"ts":"2026-06-29","kind":"sec.form144","reporter":"JOHN M EVANS","title":"Officer, Director","shares":25000,"usd_value":887353,"security_title":"Common","approx_sale_date":"2026-06-29","accession_number":"0001950047-26-006578","importance":40.1774705},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Evans John M.","title":"CEO","shares":13421,"price_per_share":35.1336,"usd_value":471528,"security_title":"Common Stock","importance":35.4715280456},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Evans John M.","title":"CEO","shares":11579,"price_per_share":35.9119,"usd_value":415824,"security_title":"Common Stock","importance":35.4158238901},{"ts":"2026-06-29","kind":"sec.filing","form_type":"144","title":"144 — Beam Therapeutics Inc. — 2026-06-29","url_slug":"/sec/cik-0001745999/144/0001950047-26-006578","accession_number":"0001950047-26-006578","importance":30},{"ts":"2026-06-29","kind":"sec.filing","form_type":"4","title":"4 — Beam Therapeutics Inc. — 2026-06-29","url_slug":"/sec/cik-0001745999/4/0001193125-26-288078","accession_number":"0001193125-26-288078","importance":30},{"ts":"2026-06-29","kind":"sec.insider.m","reporter":"Evans John M.","title":"CEO","shares":18663,"price_per_share":0.67,"usd_value":12504,"security_title":"Common Stock","importance":15.01250421},{"ts":"2026-06-29","kind":"sec.insider.m","reporter":"Evans John M.","title":"CEO","shares":6337,"price_per_share":1.03,"usd_value":6527,"security_title":"Common Stock","importance":15.00652711},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"FMR LLC","title":null,"shares":251488,"price_per_share":35.26,"usd_value":8867467,"security_title":"Common Stock","importance":43.867466879999995},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"FMR LLC","title":null,"shares":33372,"price_per_share":35.12,"usd_value":1172025,"security_title":"Common Stock","importance":36.17202464},{"ts":"2026-06-22","kind":"sec.filing","form_type":"4","title":"4 — Beam Therapeutics Inc. — 2026-06-22","url_slug":"/sec/cik-0001745999/4/0001193125-26-277509","accession_number":"0001193125-26-277509","importance":30},{"ts":"2026-06-17","kind":"sec.insider.m","reporter":"Ciaramella Giuseppe","title":"President","shares":29000,"price_per_share":1.03,"usd_value":29870,"security_title":"Common Stock","importance":15.02987},{"ts":"2026-06-17","kind":"sec.insider.m","reporter":"Ciaramella Giuseppe","title":"President","shares":6505,"price_per_share":0.67,"usd_value":4358,"security_title":"Common Stock","importance":15.00435835},{"ts":"2026-06-08","kind":"sec.filing","form_type":"8-K","title":"8-K — Beam Therapeutics Inc. — 2026-06-08","url_slug":"/sec/cik-0001745999/8-k/0001193125-26-261693","accession_number":"0001193125-26-261693","importance":35}]}